• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments

  • Print
  • Share
  • E-mail
-
1 to 10 of 10 Results
Document Number CR260281
Results per Page

New Searchexport reports to excelExport to Excel | HelpHelp
Document Parent Analyte Analyte Specialty Complexity Effective Date
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE DAT Amphetamines II} 
CR260281 K083764 Amphetamines Toxicology / TDM MODERATE 04/28/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE DAT Barbiturates Plus} 
CR260281 K043211 Barbiturates Toxicology / TDM MODERATE 04/28/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE DAT Benzodiazepines II} 
CR260281 K221765 Benzodiazepines Toxicology / TDM MODERATE 04/28/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE DAT Cocaine II} 
CR260281 K023281 Cocaine metabolites Toxicology / TDM MODERATE 04/28/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE DAT Methaqualone} 
CR260281 K945187 Methaqualone Toxicology / TDM MODERATE 04/28/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE DAT Opiates II} 
CR260281 K013482 Opiates Toxicology / TDM MODERATE 04/28/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE DAT Phencyclidine Plus} 
CR260281 K043305 Phencyclidine (PCP) Toxicology / TDM MODERATE 04/28/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE DAT Propoxyphene Plus} 
CR260281 K043303 Propoxyphene Toxicology / TDM MODERATE 04/28/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE DAT Cannabinoids II} 
CR260281 K030213 Cannabinoids (THC) Toxicology / TDM MODERATE 04/28/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {Ethanol Gen.2} 
CR260281 K951595 Ethanol (alcohol) Toxicology / TDM MODERATE 04/28/2026

-
-